Titan Intake key facts
as of Oct 2026- Developer of AI-based patient intake software designed to automate the patient referral process.
- Titan Intake is valued at approximately $6.0M as of Oct 2026 (last reported valuation).
- It has raised $1.9M; the latest was Seed Round ($1.3M) in May 2025.
- Notable investors include Plug and Play Tech Center, SaaS Ventures, Tau Ventures, ACT House, Amplify.LA — 13 tracked in total.
- Status: Privately Held (backing).
Titan Intake's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Titan Intake: the Monday email on marks, rounds and moves
Titan Intake funding rounds
No funding rounds for Titan Intake are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Titan Intake
13+Titan Intake valuation
Titan Intake's last reported valuation was $6 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Titan Intake investors
13 investors are on record for Titan Intake, including Plug and Play Tech Center, SaaS Ventures, Tau Ventures and ACT House.
Comparable companies
Comparable enterprise systems (healthcare) names by valuation on PrivateMarketView: ThoroughCare ($53 million), Arintra ($44.3 million) and Rimidi ($32 million).
About Titan Intake
Developer of AI-based patient intake software designed to automate the patient referral process. The company's software helps specialty medical clinics to increase revenue by netting new patients, improve labor productivity through automation, and increase the patient care experience through faster onboarding and treatment, enabling healthcare professionals to reduce the processing of large referral packets.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Tulsa, OK, United States
- Founded
- 2022
- Employees
- 9
- Website
- titanintake.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.